RUNX1 and tuberculosis: Cases of AML-RGA t(8;21)(q22;q22)RUNx1-RUNX1T1 with tuberculosis (TB) required stopping anthracylines and cyclophosphamide for 3 weeks due to a risk of flaring up of TB, but with chances of increase in mortality.